Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Godman, Brian ORCID: 0000-0001-6539-6972, Bucsics, Anna, Bonanno, Patricia Vella, Oortwijn, Wija, Rothe, Celia C, Ferrario, Alessandra, Bosselli, Simone, Hill, Andrew, Martin, Antony P ORCID: 0000-0003-4383-6038, Simoens, Steven
et al (show 42 more authors) (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. FRONTIERS IN PUBLIC HEALTH, 6 (DEC). 328-.


Godman, Brian, McCabe, Holly, Leong, Trudy D, Mueller, Debjani, Martin, Antony P ORCID: 0000-0003-4383-6038, Hoxha, Iris, Mwita, Julius C, Rwegerera, Godfrey Mutashambara, Massele, Amos, Costa, Juliana de Oliveira
et al (show 45 more authors) (2020) Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 20 (1). pp. 1-26.


Godman, Brian, Basu, Debashis, Pillay, Yogan, Almeida, Paulo HRF, Mwita, Julius C, Rwegerera, Godfrey Mutashambara, Anand Paramadhas, Bene D, Tiroyakgosi, Celda, Patrick, Okwen, Niba, Loveline Lum
et al (show 23 more authors) (2020) Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hospital practice (1995), 48 (2). pp. 51-67.


Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Selke Krulichová, Iva, Zampirolli Dias, Carolina, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Timoney, Angela, Gustafsson, Lars
et al (show 40 more authors) (2021) Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. Expert review of pharmacoeconomics & outcomes research, 21 (4). pp. 527-540.


Godman, Brian ORCID: 0000-0001-6539-6972, Hill, Andrew, Simoens, Professor Steven, Kurdi, Amanj, Gulbinovic, Jolanta, Martin, Antony P ORCID: 0000-0003-4383-6038, Timoney, Angela, Gotham, Dzintars, Wale, Janet, Bochenek, Tomasz
et al (show 38 more authors) (2019) Pricing of oral generic cancer medicines in 25 European countries; findings and implications. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 8 (2). pp. 49-70.


Bonanno, Patricia Vella, Bucsics, Anna, Simoens, Steven, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Gulbinovic, Jolanta, Rothe, Celia, Timoney, Angela, Ferrario, Alessandra, Gad, Mohamed
et al (show 26 more authors) (2019) Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19 (3). pp. 251-261.


Godman, Brian, Basu, Debashis, Pillay, Yogan, Mwita, Julius C, Rwegerera, Godfrey Mutashambara, Paramadhas, Bene D Anand, Tiroyakgosi, Celda, Okwen, Patrick Mbah, Niba, Loveline Lum, Nonvignon, Justice
et al (show 24 more authors) (2020) Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future. FRONTIERS IN PHARMACOLOGY, 11. 108-.


Pontes, Caridad, Zara, Corinne, Torrent-Farnell, Josep, Obach, Merce, Nadal, Cristina, Vella-Bonanno, Patricia, Ermisch, Michael, Simoens, Steven, Hauegen, Renata Curi, Gulbinovic, Jolanta
et al (show 13 more authors) (2020) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 18 (1). pp. 5-16.

This list was generated on Sat Mar 16 11:16:33 2024 GMT.